Alliance Global Partners raised the firm’s price target on Myomo (MYO) to $6.75 from $6 and keeps a Buy rating on the shares after the company reported Q4 results that were ahead of the firm’s expectations given strong unit growth for the MyoPro orthotic arm brace. Following earnings, the firm cites higher revenue forecasts for its increased price target
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYO:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue